About this Research Topic
Diabetes is a global health threat and its prevalence continues to increase. Alongside the rising cost of care, this growing prevalence has greatly increased the economic burden of treating diabetes complications. Such costly complications include amputation, blindness, kidney failure and strokes. It is therefore important to understand the factors contributing to this burden, novel models of assessing this burden, and ways in which health services can be improved to reduce this burden.
As part of the journal’s mission to address key subjects on the improvement of clinical services in relation to diabetes complications, Frontiers in Clinical Diabetes and Healthcare is organizing a Research Topic focused on the ‘The Economic Implications of Treating Diabetes Complications'. Led by an expert team of specialists, this Research Topic will accept manuscripts within this area of research, with the aim of giving the reader an overview of the latest discoveries and new findings, analysis of previously published data, new opinions and perspectives, and methods and protocols (when relevant). For that reason, all article types accepted by Frontiers are encouraged.
Specific themes of interest include, but are not limited to:
- Economic models for the treatment of diabetes complications
- Factors contributing to the economic impact of diabetes complications
- Affordability and patient access to therapies
- Cost effectiveness analysis of treating diabetes complications
- The relationship between burden of disease and cost of care
- Ways of reducing the economic burden of treating diabetes complications
Declaration: Topic Editor Dr. Rhodri Saunders is the owner of Coreva Scientific, who are currently working with Medtronic, Boston Scientific, and Cardinal Health. He has previously previously consulted for Abbott, Eli Lilly, and Novo Nordisk and was previously was one of the lead developers of the PRIME type 1 diabetes model. Topic Editor Dr. Peter Mallow Managing Member of Mallow Research, LLC – a boutique consulting firm engaging in health economic and outcomes research. Mallow Research, LLC reports consulting relationships with: Johnson and Johnson, One Tall Tree, LLC, Urgo North America, Gentherm, and TruRelief.
As part of the journal’s mission to address key subjects on the improvement of clinical services in relation to diabetes complications, Frontiers in Clinical Diabetes and Healthcare is organizing a Research Topic focused on the ‘The Economic Implications of Treating Diabetes Complications'. Led by an expert team of specialists, this Research Topic will accept manuscripts within this area of research, with the aim of giving the reader an overview of the latest discoveries and new findings, analysis of previously published data, new opinions and perspectives, and methods and protocols (when relevant). For that reason, all article types accepted by Frontiers are encouraged.
Specific themes of interest include, but are not limited to:
- Economic models for the treatment of diabetes complications
- Factors contributing to the economic impact of diabetes complications
- Affordability and patient access to therapies
- Cost effectiveness analysis of treating diabetes complications
- The relationship between burden of disease and cost of care
- Ways of reducing the economic burden of treating diabetes complications
Declaration: Topic Editor Dr. Rhodri Saunders is the owner of Coreva Scientific, who are currently working with Medtronic, Boston Scientific, and Cardinal Health. He has previously previously consulted for Abbott, Eli Lilly, and Novo Nordisk and was previously was one of the lead developers of the PRIME type 1 diabetes model. Topic Editor Dr. Peter Mallow Managing Member of Mallow Research, LLC – a boutique consulting firm engaging in health economic and outcomes research. Mallow Research, LLC reports consulting relationships with: Johnson and Johnson, One Tall Tree, LLC, Urgo North America, Gentherm, and TruRelief.
Keywords: Economics, Diabetes, Complications, Treatment, Cost, Burden, Health Services, Models
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
